Wed, 24.04.2019 @18:00
in Science lounge, D-BSSE
[add to iCal]
categories:
About the event
Gallery
About the event
MaxWell Biosystems AG, an ETH-spinoff company founded in 2016, develops platforms for cell-based assays used in preclinical drug discovery, safety pharmacology and basic neuroscientific research.
They will present their journey of founding, funding and developing a technology-based company.
Additionally, we will get the chance to hear about MaxTwo, their latest high-throughput electrophysiology product, targeting the pharma and biotech market.
As always, the talk will be followed by a networking apéro, where you’ll have some more time to talk with the speakers.
For registration, please log in and book your place below
If you are not affiliated with any Swiss university anymore and would like to register for this event, please e-mail us (bsse-industry@bsse.ethz.ch) or use our contact form.
BOOKINGS
Information about the booking process on the "Next Events" tab!Bookings are closed for this event.